Table 2.

Clinical Characteristics of the Symptomatic Plasma Cell Disorder (PCD) Subset

	PCD	Sex	Race	Age at Renal Transplant	Age at PCD Diagnosis	Clone Subtype	Initial Treatment	PCD at Last Follow-up	Renal Allograft Status at Last Follow-up
1	SMM	Male	Black	61	62	Lambda	None	SMM	No rejection
2	SMM	Male	Black	52	67	Lambda	None	SMM	Rejection
3	MM	Male	White	67	68	Lambda	VD-AutoHCT	MM	Rejection
4	MM	Male	White	49	66	Kappa	Hospice	MM	No rejection
5	MM	Male	Black	63	67	Lambda	VCD	MM	No rejection
6	MM	Male	White	46	46	Lambda	VCD-AutoHCT	MM	No rejection
7	MGRS	Male	White	81	86	Lambda	VCD	MM	Rejection
8	MGRS	Male	White	70	75	Lambda	VCD	MGRS	No rejection
9	MGRS	Male	White	41	47	Lambda	VCD	MM	Rejection
10	MGRS	Male	White	31	54	Lambda	VCD	MGRS	No rejection
11	AL	Female	White	62	69	Lambda	VCD	AL	Rejection
12	SEP	Female	White	53	62	Lambda	Radiation	SEP	Rejection

Abbreviations: AL = light-chain amyloidosis; MGRS = monoclonal gammopathy of renal significance; MM = multiple myeloma; SEP = solitary extramedullary plasmacytoma; SMM = smoldering multiple myeloma; VD = velcade dexamethasone; VCD = velcade cyclophosphamide dexamethasone; VCD-AutoHCT = velcade cyclophosphamide dexamethasone-autologous hematopoietic stem cell transplant.